Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study, Chenyang Wang, Michael K Rooney, Christopher Alvarez-Breckenridge, et al.
The Genomic Alterations in Glioblastoma Influence the Levels of CSF Metabolites, Daniel H Wang, Yoko Fujita, Antonio Dono, et al.
From Primary Myelofibrosis to Chronic Myeloid Leukemia, BCR::ABL1+ B-lymphoblastic Leukemia, and Back to Primary Myelofibrosis: An Illustration of Dynamic Clonal Evolution, Devin Wang, Wataru Kamata, Fengxi Ye, et al.
Targeting the Glutamine-Arginine-Proline Metabolism Axis in Cancer, Di Wang, Jiang-Jie Duan, Yu-Feng Guo, et al.
Protocol for Seahorse Analysis of Ex Vivo Mouse Brown and White Adipose Tissues, Fenfen Wang, Phu M Huynh, and Yu A An
MR-Guided Stereotactic Radiation Therapy for Head and Neck Cancers, He Wang, Jinzhong Yang, Anna Lee, et al.
Shewanella Phage Encoding a Putative Anti-crispr-Like Gene Represents a Novel Potential Viral Family, Hongmin Wang, Kaiyang Zheng, Min Wang, et al.
A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS), Li Wang, Yao Ding, Teresa L Bruno, et al.
A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy, Li Wang, Jeremiah Sanders, John F Ward, et al.
Identifying Mage-A4-Positive Tumors for TCR T Cell Therapies in Hla-A∗02-Eligible Patients, Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail, et al.
MUC20 Regulated by Extrachromosomal Circular DNA Attenuates Proteasome Inhibitor Resistance of Multiple Myeloma by Modulating Cuproptosis, Xiaobin Wang, Yingqing Shi, Hua Shi, et al.
Impact of Individual Level Uncertainty of Lung Cancer Polygenic Risk Score (Prs) on Risk Stratification, Xinan Wang, Ziwei Zhang, Yi Ding, et al.
Vertebral Hu Value and the Pectoral Muscle Index Based on Chest Ct Can Be Used To Opportunistically Screen for Osteoporosis, Xiong-Yi Wang, Sheng Pan, Wei-Feng Liu, et al.
Safety and Effectiveness of Using Disposable Ultrasonic Shears to Coagulate 5–7 mm Blood Vessels: Protocol for a Prospective, Multicenter, Randomized, Parallel Controlled, Non-Inferiority Clinical Trial, Xipeng Wang, Chengqiang Li, Junqiang Fan, et al.
TRIM44 Enhances Autophagy via SQSTM1 Oligomerization in Response to Oxidative Stress, Yuqin Wang, Lin Lyu, Trung Vu, et al.
Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation, Kerollos Nashat Wanis, Henry M Kuerer, Susie X Sun, et al.
Jennifer A Wargo, Nadim J Ajami, and Carrie R Daniel-MacDougall, Jennifer A Wargo, Nadim J Ajami, and Carrie R Daniel-MacDougall
Pathological Response in Resectable Non-small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis, Nathalie A Waser, Melanie Quintana, Bernd Schweikert, et al.
Glial Progenitor Heterogeneity and Plasticity in the Adult Spinal Cord, Haichao Wei and Jia Qian Wu
Minimal Information for Studies of Extracellular Vesicles (MISEV2023): From Basic to Advanced Approaches, Joshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Minimal Information for Studies of Extracellular Vesicles (MISEV2023): From Basic to Advanced Approaches, Joshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing: Efficiency and Financial Impacts, Julius Weng, Shane Mesko, Gregory Chronowski, et al.
Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images, Zhuoyu Wen, Danni Luo, Shidan Wang, et al.
First-in-Human Dose Escalation Trial To Evaluate the Clinical Safety and Efficacy of an Anti-MAGEA1 Autologous Tcr-Transgenic T Cell Therapy in Relapsed and Refractory Solid Tumors, Martin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial, Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.